Literature DB >> 15039314

N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.

Dongxu Liu1, Xiaogang Gu, Jennifer Scafidi, Alvin E Davis.   

Abstract

C1 inhibitor (C1INH) prevents endotoxin shock in mice via a direct interaction with lipopolysaccharide (LPS). This interaction requires the heavily glycosylated amino-terminal domain of C1INH. C1INH in which N-linked carbohydrate was removed by using N-glycosidase F was markedly less effective in protecting mice from LPS-induced lethal septic shock. N-deglycosylated C1INH also failed to suppress fluorescein isothiocyanate (FITC)-LPS binding to and LPS-induced tumor necrosis factor alpha mRNA expression by the murine macrophage-like cell line, RAW 264.7, and cells in human whole blood. In an enzyme linked immunosorbent assay, the N-deglycosylated C1INH bound to LPS very poorly. In addition, C1INH was shown to bind to diphosphoryl lipid A (dLPA) but only weakly to monophosphoryl lipid A (mLPA). As with intact LPS, binding of N-deglycosylated C1INH to dLPA and mLPA was diminished in comparison with the native protein. Removal of O-linked carbohydrate had no effect on any of these activities. Neither detoxified LPS, dLPA, nor mLPA had any effect on the rate or extent of C1INH complex formation with C1s or on cleavage of the reactive center loop by trypsin. These data demonstrate that N-linked glycosylation of C1INH is essential to mediate its interaction with the LPA moiety of LPS and to protect mice from endotoxin shock.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039314      PMCID: PMC375168          DOI: 10.1128/IAI.72.4.1946-1955.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells.

Authors:  G De Becker; V Moulin; B Pajak; C Bruck; M Francotte; C Thiriart; J Urbain; M Moser
Journal:  Int Immunol       Date:  2000-06       Impact factor: 4.823

2.  Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide.

Authors:  S Viriyakosol; J C Mathison; P S Tobias; T N Kirkland
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

3.  A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins.

Authors:  A D Ferguson; W Welte; E Hofmann; B Lindner; O Holst; J W Coulton; K Diederichs
Journal:  Structure       Date:  2000-06-15       Impact factor: 5.006

4.  Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide.

Authors:  F Stelter; H Loppnow; R Menzel; U Grunwald; M Bernheiden; R S Jack; A J Ulmer; C Schütt
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4.

Authors:  A Mansell; A Reinicke; D M Worrall; L A O'Neill
Journal:  FEBS Lett       Date:  2001-11-23       Impact factor: 4.124

Review 6.  Gram-negative sepsis: a dilemma of modern medicine.

Authors:  R C Bone
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

7.  Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.

Authors:  I Nagaoka; S Hirota; F Niyonsaba; M Hirata; Y Adachi; H Tamura; D Heumann
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

Review 8.  C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema.

Authors:  C Caliezi; W A Wuillemin; S Zeerleder; M Redondo; B Eisele; C E Hack
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

9.  Monophosphoryl lipid A activates both human dendritic cells and T cells.

Authors:  Jamila Ismaili; Joëlle Rennesson; Ezra Aksoy; Johan Vekemans; Benoit Vincart; Zoulikha Amraoui; Francois Van Laethem; Michel Goldman; Patrice M Dubois
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

10.  MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor.

Authors:  Jean da Silva Correia; Richard J Ulevitch
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

View more
  9 in total

Review 1.  C1 inhibitor: biologic activities that are independent of protease inhibition.

Authors:  Alvin E Davis; Shenghe Cai; Dongxu Liu
Journal:  Immunobiology       Date:  2006-12-11       Impact factor: 3.144

Review 2.  Biological activities of C1 inhibitor.

Authors:  Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal:  Mol Immunol       Date:  2008-07-31       Impact factor: 4.407

3.  N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.

Authors:  Dongxu Liu; Cort C Cramer; Jennifer Scafidi; Alvin E Davis
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.

Authors:  Robert F Mullins; Elizabeth A Faidley; Heather T Daggett; Catherine Jomary; Andrew J Lotery; Edwin M Stone
Journal:  Exp Eye Res       Date:  2009-07-14       Impact factor: 3.467

5.  Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity.

Authors:  Ebbe Billmann Thorgersen; Judith K Ludviksen; John D Lambris; Georgia Sfyroera; Erik Waage Nielsen; Tom Eirik Mollnes
Journal:  Innate Immun       Date:  2009-08-26       Impact factor: 2.680

Review 6.  The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor.

Authors:  Anneza Panagiotou; Marten Trendelenburg; Michael Osthoff
Journal:  Front Immunol       Date:  2018-05-25       Impact factor: 7.561

7.  The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease.

Authors:  Rolf Spirig; Janice Tsui; Sidney Shaw
Journal:  Cardiol Res Pract       Date:  2012-04-22       Impact factor: 1.866

8.  Estrogen/ERα signaling axis participates in osteoblast maturation via upregulating chromosomal and mitochondrial complex gene expressions.

Authors:  Pei-I Lin; Yu-Ting Tai; Wing P Chan; Yi-Ling Lin; Mei-Hsiu Liao; Ruei-Ming Chen
Journal:  Oncotarget       Date:  2017-12-19

9.  In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.

Authors:  Zhengwei Chen; Qinying Yu; Qing Yu; Jillian Johnson; Richard Shipman; Xiaofang Zhong; Junfeng Huang; Sanjay Asthana; Cynthia Carlsson; Ozioma Okonkwo; Lingjun Li
Journal:  Mol Cell Proteomics       Date:  2021-04-20       Impact factor: 5.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.